Federated Hermes
VIGL

Federated Hermes’s Vigil Neuroscience VIGL Stock Holding History

Federated Hermes’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-313
Closed -$532 – 2204
2024
Q4 		$532 Buy
313
+115
+58% +$340 ﹤0.01% 2041
2024
Q3 		$673 Hold
198
– – ﹤0.01% 1988
2024
Q2 		$792 Sell
198
-119
-38% -$407 ﹤0.01% 1954
2024
Q1 		$1.08K Buy
+317
New +$990 ﹤0.01% 1956

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Federated Hermes's VIGL Position: Q1 2025 in Review

Federated Hermes sold out of Vigil Neuroscience (VIGL) in Q1 2025, closing a stake of 313 shares — an estimated $532 sold.

Federated Hermes first reported a position in VIGL in Q1 2024 and held it in 4 quarters. The position peaked at $1.08K in Q1 2024. 50 funds tracked by Wall St. Rank hold VIGL as of Q1 2025.

  • Federated Hermes reported no remaining Vigil Neuroscience position as of Q1 2025 after selling out during the quarter.
  • Federated Hermes sold 313 Vigil Neuroscience shares in Q1 2025, an estimated $532.
  • Federated Hermes first reported a position in Vigil Neuroscience in Q1 2024 and held it in 4 quarters.
  • Federated Hermes's Vigil Neuroscience position peaked at $1.08K in Q1 2024.
  • 50 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q1 2025.

Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.